Additional information
Yellow Powder
59-30-3
ACI-060700
224.4ºC(decompose)
C19H19N7O6
441.4
Ambient
2-8°C
Anticancer
Pharmaceutical Impurity Standards
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl) methyl] amino]benzoyl] amino]pentanedioic acid
(2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoyl]amino]pentanedioic acid
Folic Acid;N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic Acid





![LINAGLIPTIN DES-PIPERIDINE AMINE (25 mg) (7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-3,7-dihydro-1H-purine-2,6-dione)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)